Wednesday, August 17, 2022
wellness India Expo
Home Tags MedGenome

Tag: MedGenome

MedGenome Labs now offering clonoSEQ® Assay in India

clonoSEQ is the 1st U. S. Food and Drug Administration (FDA) cleared MRD test for Multiple Myeloma, Chronic Lymphoblastic Leukaemia (CLL), and B-Acute Lymphoblastic Leukaemia (B-ALL)

MedGenome’s novel software to detect genetic variants for rare diseases &...

The software claims to accurately predict and rank a pathogenic variant in 90% of rare diseases cases with no or minimum manual intervention

MedGenome announces leadership transitions: Mahesh Pratapneni new Group CEO & Felix...

Co‐Founder Sam Santhosh steps down as Chairman and Group CEO; will remain on Board of Directors

MedGenome Labs acquires Trident Diagnostics, aims to expand diagnostic portfolio

MedGenome Labs has acquired Trident Diagnostics to aid research and development for creating faster, effective and accurate tests results that will contribute to providing better diagnosis with comprehensive test menu....................

MedGenome & Emmes launch genomics strategic partnership focused on advancing rare...

The two companies have partnered to support the advancement of public health and biopharmaceutical innovation, aimed at accelerating breakthrough treatments, powered by human genomics, for rare disease patients

Full-Stack agri-tech startup Gramophone raises US$ 10 Million

Gramophone is a market leading agri-tech company that provides Agronomy Services, Input and Output products in Madhya Pradesh, Chattishgarh, Maharashtra, and Rajasthan by way of an eCommerce marketplace........................

The secret behind pre-existing immunity in individuals unexposed to COVID-19

A new study suggests robust pre-existing T-cell immunity against the SARS-CoV-2 virus in individuals unexposed to COVID-19....................

MedGenome launches tumor mutation burden test for better understanding of immuno-therapy

The test will help clinicians identify how many mutations occur in a given length of DNA to understand whether immunotherapy would work in cancer patients.................

Gallbladder cancer vaccine candidates identified

The researchers' team including that from India performed a comprehensive genomic analysis and identified several targetable genomic alterations through sequencing and analysis of over 150 gallbladder cancer (GBC) samples. Currently, there are no targeted therapies for treating this cancer...............

Experts develop a new breakthrough genetic risk score for heart disease...

MedGenome Labs has conducted a first-ever study on Indian population that validates a novel ‘CAD-PRS’ (coronary artery disease-genome-wide polygenic risk score) to precisely predict the risk of developing a coronary artery disease/myocardial infarction (MI) using a person’s genetic makeup.....................